Cremolini, Chiara
Antoniotti, Carlotta
Moretto, Roberto
Masi, Gianluca
Falcone, Alfredo
Article History
First Online: 17 January 2017
Competing interests
: C.C. has received payment for consultancy and honoraria for speaking from Amgen, Bayer, Eli-Lilly, Merck Serono, and Roche. A.F. has received payment for consultancy and honoraria for speaking from Amgen, Bayer, Celgene, Eli-Lilly, Merck Serono, and Roche. The other authors declare no competing interests.